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Abstract 
The growing needs for analytical devices requiring smaller sample volumes, 
decreased power consumption and improved performance have been driving forces 
behind the rapid growth in nanomaterials research.  Due to their dimensions, 
nanostructured materials display unique properties not traditionally observed in bulk 
materials. Characteristics such as increased surface area along with enhanced 
electrical/optical properties make them suitable for numerous applications such as 
nanoelectronics, photovoltaics and chemical/biological sensing. In this review we 
examine the potential that exists to use nanostructured materials for biosensor devices. 
By incorporating nanomaterials, it is possible to achieve enhanced sensitivity, an 
improved response time and smaller size. Here we report some of the success that has 
been achieved in this area. Many nanoparticle and nanofibre geometries are 
particularly relevant, in this paper however we specifically focus on organic 
nanostructures, reviewing conducting polymer nanostructures and carbon nanotubes.  
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Introduction 
Investment in nanomaterials research has grown exponentially over the last number of 
years. This is due to the huge range of opportunities afforded by nanomaterials in 
areas such as clean energy (for example solar panels and hydrogen storage), 
environmental monitoring (sensors for harmful chemicals or biological agents), 
improved materials (such as stronger/lighter plastics and antimicrobial surfaces), and 
new products (for example nanoscale transistors). It is clear that nanotechnologies 
come with the potential to drive economic growth, hence in 2000 the US government 
set up the National Nanotechnology Initiative and since then investment has grown 
annually (Figure 1).  The investment by NNI member agencies for 2011 is nearly $1.8 
billion (http://www.nano.gov/). Currently most commercial success has resulted from 
the incorporation of nanomaterials into composites for reinforcement. This improves 
the strength of materials which can typically be used in products such as sports 
equipment (for example Babolat tennis rackets). Nanomaterials are also of interest for 
a number of other applications such as nanoelectronics (IBM and Intel both have 
active nanomaterials research programs). It is clear that nanotechnology will feature 
in many future products. Here we focus on the potential they offer for developing 
improved biosensors.  
 
Nanomaterials are defined as matter with dimensions between 1 and 100 nm (Figure 
2). To put this into perspective, a sheet of paper is about 100,000 nanometers thick 
whereas a single gold atom is about a third of a nanometer in diameter. Nanomaterials 
therefore are larger than individual atoms/molecules but smaller than bulk materials, 
and thus have characteristic properties that neither completely obey quantum- nor 
classical-physics. Nanoparticles can be zero-, one-, or two-dimensional. The low 
dimensionality of nanoparticles results in large surface-to-volume ratios, and 
enhanced electronic and optical properties when compared with bulk samples of the 
same material. They are of interest for numerous applications including sensing, 
where the large surface area of nanomaterials specifically facilitates interaction with 
an increased number of target molecules when compared to their bulk counterparts (1-
5). Their small size is also responsible for superior electronic and optical properties 
which, due to quantum confinement effects, are very sensitive to minor perturbations. 
Thus nanomaterials can be used to facilitate label-free detection, and develop 
biosensors with enhanced sensitivities and improved response times. The use of 
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nanoparticles in biosensors is increasing due to this enhancement in sensitivity (as 
seen in Table 1), which is of major importance for clinical diagnostics as the 
concentration of targets can be very low in biological samples.  A good example of 
this is DNA sensors which generally rely on polymerase chain reaction (PCR) for 
signal amplification. By developing biosensors with improved sensitivity it will 
eliminate the need for PCR and thus simplify DNA biosensors. This can be achieved 
using nanomaterials which, due to their large surface area, allow a greater number of 
DNA strands to be immobilised (6). Nanomaterials can be incorporated into many 
types of biosensor configurations to develop magnetic, optical, electrical or 
electrochemical biodevices for the detection of many biological molecules including 
nucleic acids, antibodies, proteins, toxins and bacteria (7-13)  
 
The first biosensors were reported in the early 1960’s, where a pH response for a 10 
mg per cent solution of glucose was reported (14). Since then there have been many 
advances made in the field, and devices are now more sensitive and more portable.  In 
general, a biosensor can be described as a device which has a biological sensing 
element connected to (or integrated with) a transducer, thus transforming a biological 
event into a signal which can then be interpreted. The recognition biomolecule within 
a biosensor is highly selective, and can be immobilised by physical adsorption, 
entrapment or covalent attachment (8, 15-18). The sensitivity of a biosensor is 
dependent on the number and accessibility of recognition biomolecules present. 
Nanomaterials enable the development of improved biosensors because they allow for 
incorporation of a greater number of recognition biomolecules which are more readily 
accessible to the target species, owing to greater porosity and surface area. 
Nanomaterials thus typically enable lower detection limits and faster response times, 
they can also enable label-free detection which is a major advantage (19, 20). Many 
types of nanomaterials are suitable for biosensor applications including metallic 
nanoparticles (such as gold), magnetic nanoparticles (such as iron oxide), 
semiconducting nanoparticles (such as quantum dots and silicon nanowires), and 
organic nanoparticles (such as conducting polymers, carbon nanotubes) (13, 20-25). 
Organic materials are more likely to be biocompatible and in this review article we 
will consider only organic nanomaterials, in particular we review conducting polymer 
nanostructures (CPs) and carbon nanotubes (CNTs).  
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1. Nanomaterials 
1.1 Carbon Nanotubes 
 
Carbon nanotubes (CNTs), discovered by Iijima in 1991 (26), are an allotrope of 
carbon comprised of graphene sheets rolled up into cylinders of sp2 hybridized atoms. 
CNTs exist as single- (SWNTs), double- (DWNTs) and multi-walled (MWNTs) 
structures. MWNTs are essentially a number of concentric SWNTs and hence have a 
larger diameter (Figure 3). The diameter for SWNTs is usually less than 2nm, whereas 
diameters for MWNTs range between 2-100 nm, depending on the number of shells 
present. CNTs are typically microns long but, tubes up to 4cm in length have been 
reported (27). Combined with their narrow diameter, this leads to excellent material 
properties such as a high aspect ratio and large surface area. CNTs can be 
approximated to one-dimensional nanostructures, as a result (28).  
 
The electrical properties of a CNT are determined by the tube helicity and diameter 
(Figure 4) (8). If a CNT is imagined as a rolled-up graphene sheet, the helicity of the 
tube depends on the angle at which it is rolled-up, and can be described by its chiral 
vector, Ch =  na1 + ma2 (where a1 and a2 are unit vectors of the hexagonal lattice and, 
n and m are integers) (28). The direction of Ch is perpendicular to the axis of the 
nanotube. The chiral angle (θ), is the angle between vectors Ch and a1. The n, m and θ 
values for a particular CNT, determine the electronic behaviour of the tube. If n - m is 
a multiple of 3 the tube is metallic otherwise, the tube is semiconducting (28). This 
stipulates that one-third of all tubes are metallic with the remaining two-third 
semiconducting. 
 
The exponential increase in CNT patents filed in recent years reflects the level of 
commercial interest. However, applications for CNTs are currently limited by the 
difficulties associated with purification and the lack of precise control over the 
properties (such as chirality) of CNTs produced. At the moment, production of 
exactly one type of CNT is limited to the number of walls on the CNT, with some 
SWNT batches even containing DWNTs and MWNTs, among other types of 
nanostructured carbon. Exact production of a single type of chiral or semi-conducting 
SWNT, without contaminants, is unfortunately not yet possible and considerable 
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batch to batch variation is also common. In addition, no clear cut strategy for 
purification of CNT type has been discovered to date. Therefore current CNT research 
is limited to working with CNT mixtures. 
 
Early CNT research primarily focused on determining and exploiting the properties of 
the pristine materials. More recently however, exploration into the chemistry of 
CNTs, including their functionalisation, has begun to dominate the field (29, 30). The 
first attempts at chemical functionalisation of CNTs were in response to their poor 
solubility. Pristine CNTs align parallel with one another to form bundles (31), thus 
increasing van der Waals interactions, but also preventing their dissolution. Although 
pristine CNTs have been shown to form stable dispersions with the aid of surfactants 
(32) and biomolecules (33) or low concentration dispersions with short-term stability 
in amides such as N,N-dimethylformamide (DMF), N-methylpyrrolidone (NMP), and 
other non-hydrogen bonding Lewis bases (34) better methods for solvation are 
required. 
 
CNTs are susceptible to functionalisation mediated by oxidative processes that form 
reactive groups at their end-caps and defect sites, or by direct modification of their 
sidewalls, both covalently and non-covalently. Covalent attachment involves the 
direct addition of functionality to CNTs via the formation of chemical bonds, whereas 
non-covalent attachment involves CNT-molecule interactions involving electrostatic, 
van der Waals and/or hydrophobic interactions. A high degree of covalent 
functionalisation, which alters carbon-carbon bonds from sp2 to sp3 structure, can 
however, result in a sizeable loss of electrical conductivity of the functionalised 
SWNTs (35). 
 
Since the purification of CNTs is often carried out using oxidative methods that 
introduce carbonyl and carboxylic acid groups on the open ends of the CNTs and at 
defect sites along the CNT sidewalls (36-39), this has become one of the favoured 
routes of covalently attaching biomolecules to CNTs. The proliferation of amino 
functionalities on proteins, enzymes and antibodies among other biomolecules, allows 
for facile amide functionalisation with CNT carboxylates (Figure 5). A wide variety 
of biomolecules such as carbohydrates (40), oligonucleotides (41), proteins (42, 43), 
enzymes (44, 45) and even DNA (46-48) have been attached to CNTs in this fashion. 
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However, such functionalisation can be difficult to reproduce since the extent of 
functionalisation is dependent on the degree and type of nanotube carboxylation, 
which in turn varies according to CNT source. 
 
Although rather uncontrollable, non-covalent attachment (physical adsorption) has 
been used effectively to attach a variety of moieties to CNTs. Unfortunately, proteins 
and antibodies in particular, may lose their biological activity when adsorbed on a 
CNT surface. This can be due to a change in conformation when binding with the 
CNT and/or unfavourable orientation of the active site. The interaction of 
biomolecules with CNTs has been of particular interest with a view to their use as 
biosensors (49) or improving biocompatibility (50). Non-covalent binding of 
streptavidin to CNTs has been achieved via covalent attachment to linkers that are 
adsorbed along the CNT axis (51). DNA has been shown to strongly interact with 
CNTs, forming uniform coatings (52). The wrapping of CNTs has recently been 
extended to other biopolymers including chitosan, chondroitin sulphate and 
hyaluronic acid (53, 54). Biomolecules of interest, including antibodies, may 
subsequently be anchored to these biopolymers wrapped around the CNTs (55). 
 
 
1.2 Conducting Polymer Nanostructures 
CPs are of interest for biosensor applications as they can be interfaced with 
biomolecules for effective signal transduction. CPs can be tailored to create substrates 
with a high surface area, controllable morphology and conductivity. These properties 
make them excellent transducer materials which can facilitate rapid electron transfer 
between immobilised biomolecules and an electrode surface (56). Like 
metals/semiconductors, CPs can conduct charge carriers such as holes and electrons. 
Unlike metals/semiconductors however they are low cost, and can be easily prepared 
and modified (57). In 1977 Alan Heeger, Alan, MacDiarmid and Hideki Shirakawa 
discovered that when polyacetylene was exposed to bromine vapours, its conductivity 
rose by seven orders of magnitude (58). Polyacetylene is a pi-conjugated polymer 
meaning there are alternating single and double bonds along the polymer backbone. In 
a conjugated polymer the pi-electrons can become delocalised and shared along the 
polymer chain, enabling them to conduct electricity. CPs are extremely useful as they 
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combine the electrical properties of a metal with the low density and cost of a 
polymer. Potential applications include light emitting diodes, photovoltaics, 
electostatic discharge coatings and printable electronics (59-62). The conductivity of a 
CP is however sensitive to its chemical environment and can be varied over ten orders 
of magnitude (ranging typically from 10-10S/m to 100S/m). This change in 
conductivity results from a change in the bonding structure, and is accompanied by a 
change in the colour/spectroscopy of the material (63). Hence CPs are suitable for 
developing amperometric, potentiometric, conductometric, electrochemical, optical, 
calorimetric and piezoelectric biosensors(56). 
 
Certain CPs, such as polyacetylene, however are unstable thus limiting them from use 
in practical applications. CPs such as polyaniline (PAni), polypyrrole, polythiophenes 
and poly-ethylene-dioxythiophene (PEDOT) have greater stability and are more 
commonly investigated (Figure 6). PAni, for example, switches between a non-doped 
insulating emeraldine base form and a doped conducting emeraldine salt form (Figure 
7). Switching is reversible and accompanied by a colour change from purple to green. 
In the conductive form, delocalised electrons (called bipolarons) form along the 
polymer backbone and are responsible for charge transfer. A disruption in the 
conjugation of the polymer backbone results in a decrease in conductivity of the 
material, making it suitable for sensing applications. As PAni conductivity relies on 
protonation of the polymer by acid molecules, it’s conductivity tends to be poor in 
solutions at neutral pHs (64).  This can be dealt with by covalently attaching acid 
molecules to CP backbones, resulting in a self-doping polymer (65, 66).  
 
The conductivity of a CP is always dependant on its oxidation state, and short term 
redox stability is a limitation which all unmodified CPs suffer from. CPs also tend to 
suffer from poor mechanical properties, for example polyprrole has been reported to 
have poor ductility, and is brittle (67). Therefore, although CP films can be cast onto 
substrates, it is not generally possible to produce robust CP films with sufficient 
mechanical integrity to be free-standing. The mechanical properties of CPs can 
however, be improved by incorporating materials such as CNTs for reinforcement 
(68). CPs also tend to have poor solubility in common solvents and are typically 
hydrophobic (69). Large CP particles tend to agglomerate resulting in poor 
dispersions which are difficult to process. Using the nano- (versus bulk-) form of CPs 
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however, tend to produce more stable homogenous dispersions. Stable aqueous 
colloids of PAni nanofibres have been produced without the need for surfactant 
stabilisation (70).  
 
For sensing applications, the response time and sensitivity of detection is also 
improved for the nano- versus the bulk-form of the material (Figure 7). This is due to 
the increased number of reaction sites available for interaction with a target species 
(71). Until recently nanofibres of CPs were synthesised by solution-based methods 
such as electrospinning. However, this process can be complicated by the fact that 
most CPs are difficult to dissolve. A simpler method to synthesise nanofibres is by 
chemical means and Kaner et al. have demonstrated the synthesis of PAni nanofibres 
by interfacial polymerisation and also by a rapid mix process (72, 73). The BET 
surface area of nanofibers produced using these methods is typically in the region of 
40 m2/g (72). 
 
Like other conductive nanomaterials, CPs are of interest as they enable simultaneous 
biomolecule immobilisation along with rapid electron transfer (facilitating enhanced 
communication with an electrode surface) (74-78) (79). However, they are cheaper to 
produce when compared with many other conductive nanomaterials and properties 
such as roughness, porosity, hydrophobicity, stability and conductivity can be 
controlled. Increasing the surface roughness has been shown to increase the sensitivity 
of CP-based biosensors (80). CPs can be incorporated into numerous biosensor 
configurations to enable low limits of detection, and can be tailored to detect a range 
of target biomolecules (Table 1). A key aspect in biosensor applications is integration 
of the electrical component (CP) with the biological recognition component. After 
immobilization it is critical that molecules maintain their activity and are accessible to 
the analyte so that hybridization of complimentary oligonucleotides, antigen-antibody 
binding, or enzyme-catalysed reactions can be monitored. 
 
2. Biosensing 
Central to much sensor research is the ability to monitor biomarkers (in particular 
disease biomarkers) in ‘real-time’, with high sensitivity and selectivity in real 
untreated samples. This demand for sensitive, rapid, ‘on-site’ biosensor techniques 
has taken advantage of the latest advances in nanotechnology. To improve 
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sensitivities, intense research has been carried out in signal amplification by 
nanomaterials.  
 
2.1 CNTs 
2.1.1 CNT-Electrical sensors 
The oldest and most commonly used transducers in biosensors are electrochemical. 
Electrical detection methods are appealing because of their low cost, low power 
consumption, ease of miniaturization, and potential multiplexing capability (81, 82). 
Due to their size and electronic properties, CNTs can be used to develop highly 
sensitive and specific nanoscale biosensors (83-85). Challenges remain however in 
creating macro-sized structures that fully utilise the properties of the individual CNT 
nanocomponents. Three approaches to the development of electrochemical biosensors 
using CNTs dominate the literature (Figure 8) (86, 87). In the simplest method, CNTs 
are randomly deposited onto conductive surfaces in a mat configuration (CNT-mats) 
or packed into a micropipette for use as electrodes. This method results in an 
unknown configuration of CNTs which although easy to achieve may not offer 
optimal signals. However it allows for CNTs pre-functionalised with biomolecules to 
be used. Alternatively the CNTs can be coated with the biomolecule of interest post 
electrode fabrication. The second approach involves vertically aligned CNT forests, 
with one end in contact with the underlying electrode and the other end exposed in the 
electrolyte solution. This configuration may be achieved by growing the CNTs 
directly from the surface or by self assembly of shortened CNTs. Typically CNTs are 
functionalised after this electrode type has been assembled. A third type of 
nanoelectrode uses just a single CNT. If the type of CNT used could be exactly 
controlled (SWNT vs. MWNT, metallic vs semiconducting) this would ultimately 
give the best performance. However, the fabrication and manipulation challenges 
involved will limit its practical use.  
 
For many important enzymes direct electron transfer with conventional electrodes is 
not easily achieved or is too slow for sensor applications. CNTs are comparable in 
size to many biomacromolecules. Their nanodimensions and high aspect ratio 
therefore exploit the possibility of bringing CNTs into close proximity with proteins, 
which is not as easily achieved by bulk substrates. This close proximity allows CNTs 
to communicate with the redox-active sites of biomolecules which are sometimes 
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obscured/ inaccessible due to the surrounding insulating protein shell. Effective 
electrical communication enables CNTs to act as one dimensional channels for 
electron transfer in proteins (88-90). This electron transfer can be further enhanced by 
the rapid transfer kinetics and high electrocatalytic activity of the tips of oxidised 
CNTs (91, 92). 
 
Electrochemical sensors can be based on potentiometry, amperometry, voltammetry, 
coulometry, AC conductivity or capacitance measurements (93). Most CNT-based 
electrochemical biosensors detect biomolecules amperometrically. The range within 
which the sensor is sensitive is an important sensor parameter. Glucose sensors for 
example need to be sensitive in the range of a few µmol/l to 15 mmol/L since normal 
blood sugar levels are usually less than 6 mmol/L of glucose, while a level of 7 
mmol/L or higher implies diabetes. Since the first biosensors, measuring glucose, 
were reported in the early 60’s, it has become one of the most frequently performed 
routine analyses in medicine. It is thus hardly surprising that an enormous amount of 
literature exists on glucose biosensors and more recently CNT-based glucose 
biosensors, which are covered in some recent reviews (94-97). Here we will highlight 
some general characteristics of these biosensors and present a few pertinent examples.  
 
An example of a CNT-mat amperometric biosensor incorporated dispersed SWNTs 
with the enzyme glucose oxidase into redox polymer hydrogels (63). These enzymatic 
redox composite films resulted in up to a 10-fold increase in the oxidation and 
reduction peak currents, while the glucose electro-oxidation current was increased 3-
fold for glucose sensors. CNT-mat electrodes do not seem to provide significant 
advantages in reversibility or signal-to-noise ratio compared to the best redox protein 
films on conventional electrodes except in a few special cases (e.g. glucose oxidase) 
(98). Rubianes and Rivas (99) showed how using dispersed CNTs allowed the 
development of highly sensitive glucose biosensors without redox mediators, metals 
or anti-interferent layers. The sensitivity of the CNT-mat electrode was 43 times 
higher than that obtained with the control graphite composite electrode, with a 
clinically relevant linear range and negligible interference from ascorbic acid (AA), 
uric acid (UA) and acetaminophen; all common blood interferents. 
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Even though the nanodimensions of CNTs makes them amenable to close contact 
with the redox active centres of proteins and enzymes, Gooding and co-workers have 
demonstrated that CNTs may not fully probe the protein active site (44). In an 
interesting paper they describe how a self-assembled aligned shortened CNT forest 
probes the redox active centre of glucose oxidase, flavin adenine dinucleotide (FAD). 
In one experiment they conjugated glucose oxidase directly to the ends of the 
shortened CNTs in the aligned forest. They compared its electrochemistry to that of 
an array conjugated to the enzyme active centre, FAD, with subsequent enzyme 
reconstitution around the CNT-immobilized FAD. They found that the latter approach 
allowed for more efficient electron transfer to the glucose oxidase active centre. 
Hence, even though CNTs offer more efficient ways of communicating electrically 
with the active sites of biomolecules then traditional bulk substrates, there is still 
room for improvement when fabricating biosensors composed of them. 
 
Cholesterol sensors must have sensitivity in the range of 2.5–10 mmol/L since a total 
blood cholesterol level of less than ~5 mmol/L is considered to be risk-free, whereas 
high cholesterol levels greater than ~6 mmol/L are considered dangerous. The layer-
by-layer adsorption technique was used to immobilise cholesterol oxidase in a 
MWNT-mat immobilised on a gold electrode to create a biosensor for cholesterol 
(100). The sensor response was found to be linear in the range of 0.2–6 mmol/L. In 
another case, a screen-printed carbon paste electrode modified with a MWNT-mat and 
cholesterol oxidase could detect cholesterol directly in blood in the clinically relevant 
ranges (101). The authors noted how CNTs promoted the electron transfer; nearly 
doubled the sensitivity and improved the linearity of the electrode compared to the 
control. Furthermore, the CNT electrode results gave good correlation with results 
from clinical assays of 31 patients’ blood samples.  
 
Detecting genomic DNA sequences and identifying mutations is vital in the treatment 
of inheritable and infectious diseases. Electrochemical methods are aptly-suited to the 
detection of DNA with their high sensitivity and rapid response. CNT-based DNA 
sensors are well covered in recent reviews (94-97), therefore we will highlight using 
examples some general characteristics of these biosensors. Sensors may be fabricated 
by immobilising single-stranded DNA (ssDNA) onto an electrode, allowing 
hybridisation of the complementary DNA sequence to be detected by a current 
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change. An electroactive DNA intercalator is often used to amplify the signal. A 24-
base pair DNA could be detected using differential pulse voltammetry and the 
intercalator duanomycin, at a MWNT mat electrode modified with complementary 
ssDNA (102). This sensor exhibited good selectivity (on the order of 4 µA/nmol/L 
over a linear range of 0.2–50 nmol/L) over oligonucleotide sequences having a 
mismatch of only a few bases. When these electrodes were decorated with Pt 
nanoparticles however, a superior response was obtained, again showing the 
amplification achieved with nanoparticles (103). The limit of detection for target 
DNA using the Pt nanoparticle-modified MWNTs was 1.0×10−11 mol/L.  
 
By monitoring the electrochemical oxidation of guanine, DNA can be detected 
without an indicator. Labuda and co-workers (104) evaluated DNA biosensors from 
both the redox signals of the marker [Co(phen)3]3+ and guanine residues. They used 
screen printed electrodes modified with nanostructured mats of MWCNT, 
hydroxyapatite and montmorillonite. Based on AC voltammetric detection of guanine, 
a label-free DNA hybridization sensor was developed by attaching MWNTs onto a 
carbon paste electrode using a hybridisation assay (105). The MWNT-mat electrode 
exhibited large signal improvements compared to the control. Screen printed 
electrodes modified with MWNT, which catalysed the electrooxidation of guanine 
and adenine residues, were reported by Ye and Ju (106) for fast and sensitive 
detection of DNA and RNA. To improve the response of guanine oxidation a redox 
mediator can be used. For example, Ru(bby)2+3 allowed attomoles of oligonucleotides 
to be detected at ssDNA-modified MWNT forests (107). A 17-fold higher oxidation 
signal for DNA oxidation at CNTs compared to a glassy carbon control electrode was 
reported by Wang et al. (108). They used chronopotentiometric adsorptive-stripping 
in the presence of copper to measure the purine nucleobases (guanine in this case). 
Well defined hybridisation signals were obtained for the BRCA1 breast cancer gene 
with an LOD of 40 ng/mL. Gooding and co-workers have reported advantages of 
using bamboo type CNTs for the oxidation of DNA bases in a mat-type configuration 
(109). The presence of edge planes of graphene at regular intervals along the walls of 
the bamboo CNT were attributed to the enhancement in the oxidation signals of 
guanine residues.  
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Examples of where CNTs were used for amplified detection include enzyme-linked 
CNTs carrying numerous enzymes (110, 111). Wang et al. (112)  described the use of 
CNTs in two ways, both for the recognition and transduction events. Target DNA 
strands were labelled with CNTs carrying numerous alkaline phosphatase tags. DNA 
target strands were captured by DNA immobilised on magnetic beads. The signal of 
the target analyte underwent double step amplification in both the recognition and 
transduction events. The CNT-alkaline phosphatase enzymatic amplification was 
detected using chronopotentiometric stripping at a CNT-mat electrode. The 
potentiometric detection of DNA was demonstrated with high sensitivity using 
ssDNA connected to enzyme-loaded CNTs immobilized on a glassy carbon electrode. 
This led to a reported detection limit of 54 aM for DNA.  
 
Immunosensors are a good alternative to traditional immunoassays since conventional 
immunoassays such as enzyme-linked immunosorbent assay (ELISA) can be complex 
and laborious to perform. They use the high affinity reaction between an antibody, as 
recognition element, with its corresponding antigen, in combination with a transducer. 
Immunosensors can be used to monitor the presence of the antibody or antigen and 
either the antibody or the antigen can be immobilised or labelled depending on the 
assay requirements. When immobilising the antibody, it is of crucial importance that 
the method of immobilisation maintains the stability and activity of the antibody.  
 
To boost the detection sensitivity of PSA (prostate specific antigen, a biomarker for 
prostate cancer) in serum, an amplification step was incorporated by combining 
SWNT forest immunosensors with HRP-MWNT-Ab2 bioconjugates. The secondary 
antibody (Ab2) and HRP tag were covalently linked to MWNTs at high ratios of 
1:200 (89). This amplification strategy improved the detection limit 100-fold to 4 pg 
ml-1 and the sensitivity by 800-fold, compared to conventional ELISA. These results 
highlight the excellent promise CNTs show in ultrasensitive immunoassay research in 
proteomics and systems biology. 
 
CNT-FETs 
In addition to electrochemical sensors using CNTs as an electrode substrate, sensors 
based on transistor arrangements using CNTs have been developed (113). SWNTs are 
the most likely candidate for miniaturizing electronics beyond the micro 
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electromechanical scale currently used in electronics. They exhibit electric properties 
not shared by their multi-walled counterparts and certain sizes of SWNT act as 
semiconductors. The intrinsic bandgap in semiconducting SWNTs (typically 0.5eV, 
but this is diameter-dependent) allows them to be used as nanosized semiconducting 
channels in field-effect transistors (FETs) (114). Since FET-based biomolecular 
detection does not employ fluorescence, electrochemical, or magnetic tags it has been 
termed as ‘label-free’ methodology (115-117). FETs generally consist of a substrate 
(gate), two microelectrodes (source and drain), and a SWNT (or SWNT network) that 
bridges the electrodes. Usually SWNTs are grown directly via chemical vapour 
deposition (CVD) or cast from a dispersion onto a substrate either before or after the 
electrodes are patterned (118). Single-nanotube FETs require arduous screening of 
devices to eliminate metallic SWNTs. This need is obviated for nanotube networks 
cast from dispersions, where the 2 to 1 ratio of semiconducting to metallic SWNTs 
renders the likelihood of forming a continuous metallic pathway between source and 
drain unlikely. Sensing is based on the fact that the current flow in SWNT FETs is 
extremely sensitive to the binding of biomolecules and produces a detectable signal. A 
wide variety of applications for CNT FETs have been investigated, including the 
detection of proteins, antibody-antigen interactions, glucose, DNA and DNA 
hybridization. The detection limit for the sensing of proteins or protein-protein 
interactions has generally been in the range of 100 pM to 100 nM (98).  
 
An SWNT-FET binding assay typically involves first immobilising a biological 
receptor, for example, a nucleotide, aptamer, antibody, or cofactor, thus providing 
recognition sites for target analytes, for example, complementary DNA strand, 
protein, antigen, or apo-protein. The current–voltage characteristics or conductance of 
the receptor-modified SWNT-FET are measured prior to analyte binding. This is 
generally followed by a blocking step to minimize non-specific binding of targets. 
Finally, the current–voltage characteristics or conductance of the SWNT-FET device 
is measured following exposure to the analyte (119).  
 
50-amino-modified aptamers (oligonucleic acid or peptide molecules that bind to a 
specific target molecule) immobilised on a CNT-FET were used to detect 
immunoglobulin E (IgE) (120). The net current change increased with the IgE 
concentration and a detection limit for IgE of 250 pM was reported. Li et al. (121) 
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studied the detection of PSA with a FET comprised of a network of SWNTs. The 
authors measured the electronic interaction of an anti-PSA antibody in the act of 
capturing PSA. The interaction is thought to be a charge-transfer mechanism with a 
reported limit of detection of 14 pM, at a signal-to-noise ratio of 2. SWNT-FET 
biosensors can achieve pM detection limits for DNA hybridization (110) and 
antibody–antigen binding (98, 122). 
 
2.1.2 CNT-Optical sensors 
Individual semiconducting SWNTs exhibit photoluminescence, with discrete bands in 
the near-infrared region between 900 and 1600nm. Since biologically relevant 
samples such as blood and tissue have low absorption in this region, the sharp 
nanotube fluorescence spectra may be detected even in a complex biological 
environment. Such semiconducting SWNTs were used as near-IR fluorescent tags for 
cell imaging and to selectively probe cell surface receptors (123). The nanotubes were 
first non-covalently functionalised with amine groups using the surfactant PL-PEG-
NH2, followed by conjugation with antibodies recognising both the CD20 cell surface 
receptor (Rituxan) and the HER2/neu receptor on certain breast cancer cells 
(Herceptin). In vitro near-IR fluorescence imaging showed specific binding of the 
antibody-conjugated SWNTs to the host cells, with high specificity for the different 
antibodies (55:1 and 20:1 for host cells:non-host cells).  
 
Barone et al. linked enzyme reactions to CNT fluorescence, creating a sensor whereby 
an enzymatic reaction could be followed by monitoring fluorescence (124). The 
authors non-covalently functionalised SWNTs with glucose oxidase (GOx) and 
potassium ferricyanide. The functionalisation with potassium ferricyanide quenches 
the SWNT fluorescence. Addition of glucose to the GOx-SWNT sensing complex 
resulted in the ferricyanide ions leaving the surface of the CNT yielding a recovery of 
the CNT fluorescence. The authors could relate the CNT near-infrared fluorescence to 
the glucose concentration and maintain that this type of sensor, enveloped in a small 
dialysis capillary, could be implanted in the body. The capillary could allow glucose 
to diffuse in, easily allowing sugar levels to be measured. This research demonstrates 
the feasibility of using CNT sensor systems in implantable biomedical sensors. 
 
2.2 CPs 
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2.2.1 CP-Electrochemical sensors 
An L.O.D. of 3.4 x 10-10 mol/L was reported for a simple electrochemical 
oligonucleotide (ODN) sensor made using PAni nanotubes (125). Solutions used 
during PAni synthesis contain polymeric acid (polymethyl vinyl ether-alt-maleic 
acid), and hence nanotubes have residual carboxylic acid functionalities which can be 
used to covalently graft ODN via carbodiimide chemistry. The authors report that they 
expect to achieve an even lower detection limit by optimizing the nanotube surface 
area. PAni nanowires can also be synthesised electrochemically, and subsequently 
modified with oligonucleotides via EDC coupling between phosphate groups and the 
amino groups of PAni (126). Using this method the complimentary DNA target could 
be detected down to a concentration of 1 x 10-12 mol/L. DNA-functionalised 
polyaniline nanofibres (100nm diameter) can also be used to specifically detect 
Gonorrhea. Up to 0.5 × 10−15 M of complementary target could be detected by 
differential pulse voltammetry within 60 seconds of hybridisation (127). These 
electrodes are found to be highly specific to distinguish the presence of N. 
gonorrhoeae from N. meningitidis and other Gram-negative bacteria, (such as E. coli). 
The performance of this STD sensor in clinical samples is being explored by the 
authors, and findings are expected to also have implications in relation to the clinical 
diagnosis of other sexually transmitted diseases. 
 
CPs can also be used to detect many other targets for example, Dhand et al. report an 
electrode biosensor where cholesterol oxidase (ChOx) is covalently immobilised onto 
nano-structured PANI on indium tin oxide (ITO). Using this set-up good selectivity 
can be achieved and it is significant that interferants such as AA, UA, glucose, lactic 
acid, sodium pyruvate and urea were found to have a negligible effect on the sensor. 
ChOx/PANI/ITO electrodes retain about 85% activity after 11 weeks (when stored at 
4 oC) and can be used ~ 20 times with 2–3% error range. Another example of a 
cholesterol sensor is where the electropolymerisation an enzyme with laponite 
nanoparticles in a polypyrrole matrix was shown to increase the sensitivity of 
detection from 5.1 (without laponite nanoparticles) to 13.2 mA M-1 cm-2 (128). 
 
Along with good sensitivity and selectivity, nanostructured biosensors typically 
exhibit fast response times. For example an amperometric biosensor designed for the 
detection of phosphate ions has a response time of 6 seconds (129). In this example, 
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pyruvate oxidase (PyO) was covalently immobilised onto nano-particles (5-40nm) of 
poly-5,2′:5′,2″-terthiophene-3′-carboxylic acid (PTCA). The electron transfer rate 
constant from immobilised PyO was determined to be 0.65 s−1, with a detection limit 
of ~0.3 µM.  This biosensor can be stored and re-used for up to one month without 
any loss in sensitivity. A similar biosensor of PTCA nanoparticles was used to 
covalently immobilise glutamate oxide. Glutamate concentrations could be 
determined, and an LOD of 0.1µM was reported for an in vitro measurement (wherein 
the biosensor was implanted into a rat’s brain). 
 
Polypyrrole is another example of a CP which can be used in the nanoform for low 
L.O.D biomolecule detection. An example of this is where a pyrrole monomer and 
biomolecule receptor (avidin) were electropolymerised within 100 nm wide channels 
(130). When exposed to biotin−DNA, the conducting polymer nanowires generated a 
rapid change in resistance, with sensitivity as low as 1 nM. The method described 
offers advantages of direct incorporation of functional biological molecules into the 
conducting-polymer nanowire during its synthesis, site-specific positioning, built-in 
electrical contacts, and scalability to high-density nanoarrays.  Polypyrrole nanofibres 
were also developed with an even lower L.O.D of 100-200 fg mL -1. Nanofibres were 
used to detect salivary protein markers. An exceptionally low L.O.D of 10aM was 
reported by the authors for IL-8 mRNA (131). Advantages of this method are the low 
L.O.D combined with the fact that the detection method is label-free with excellent 
control over non-specific binding.  
 
2.4 CP-Optical sensors 
As well as electrochemical detection, nanostructured CPs can also be used for the 
optical detection of biomolecules. An example of this is where functionalised silica-
PPy nanocomposites were used to detect anti-HSA. Flocculation of the 
nanocomposite dispersion occurs upon anti-HSA binding and the system can therefore 
be used for visual diagnostic assays (132). Human serum albumin (HSA) is of interest 
as a target as it was previously used to detect renal disease. In another example of a 
HSA biosensor, pyrrole-propylic acid nanowires can be synthesized electrochemically 
via a templated method and subsequently modified using EDC crosslinker to 
covalently bind anti-HSA. Using this as a platform, HSA can then be detected using 
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optical or electrical methods. Using an FET configuration nanomolar levels of HSA 
were reported (133). 
 
3. Composites 
By using nanostructured (versus bulk) materials, it is possible to develop biosensors 
which exhibit higher signal-to-background ratios, shorter response times, higher 
sensitivities and greater selectivity than previous biosensor configurations. Many 
different nanostructured geometries can be used to develop biosensors with improved 
sensing capabilities. However, it is interesting to also consider hybrid composites 
composed of two or more materials (134). Using this approach the advantageous 
properties of each constituent can be exploited. CNT and CPs can be combined 
together (and also with other materials) to produce improved biosensors (19, 135). In 
general the incorporation of CNTs tend to improve the sensitivity and selectivity of a 
biosensor (69). 
 
Composites can be used to improve the selectivity of biosensors, for example in 
dopamine monitoring. Dopamine (DA) is an important neurotransmitter and abnormal 
levels can be used to diagnose certain nervous diseases such as Parkinsons and 
epilepsy. DA is easily oxidisable which can enable detection (typically levels in urine 
samples are monitored). However other electroactive compounds are present along 
with DA. In particular AA and UA can cause a problem as they oxidise at almost the 
same potential resulting in interference. Incorporation of CNTs and surfactant, along 
with CPs, have been used as ways to selectively detect DA(25). CPs can also be 
combined with gold and Mathiyarasu et al. report Poly(3,4-ethylenedioxythiophene), 
PEDOT-Au nanocomposite films for sensing DA and UA simultaneously (115 mV 
and 246 mV, for DA and UA respectively) (76). It is significant that detection can be 
achieved in the presence of excess AA which is present in both blood and urine, thus 
complicating detection. Abnormal levels of UA are symptomatic of diseases such as 
gout and Lesch-Nyhan syndrome. The PEDOT matrix contributes towards the peak 
separation (selectivity) while also promoting catalytic oxidation of the above 
compounds. Gold nano-particles facilitate nanomolar sensing (sensitivity). Thus, it is 
possible to detect nanomolar levels of DA and UA in presence of excess AA. This 
composite nanomaterial shows superior selectivity and sensitivity compared to the 
polymer film alone, and presents an interesting step forward as a major challenge is to 
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develop a sensitive and selective method for UA and DA detection (Ates et al., 
2009(25)). 
 
Gold can also be combined with other CPs, and Prabhakar et al.
 
(136) report a nucleic 
acid sensor whereby pathogen-specific DNA and PNA (peptide nucleic acid) probes 
were covalently immobilized onto a PAni-Au electrode. These nanostructured 
electrodes were then utilized for the detection of hybridization with a complementary 
sequence (M. tuberculosis in this case). The PNA-PANI/Au electrode exhibits a 
detection limit of 0.125 × 10-18 M, with the DNA-PANI/Au electrode showing 2.5 × 
10-18 M. Improved specificity (1000 times) was also observed for PNA-PANI/Au. 
Responses were observed within 30 seconds of hybridization time. These DNA-
PANI/Au and PNA-PANI/Au electrodes can be used 6−7 and 13−15 times, 
respectively. For increased sensitivity, reusability, and better detection limit, authors 
recommend the development of nanocomposites and functionalized conducting 
polymers. In this way it should be possible to detect other pathogens including 
Salmonella typhimurium and Nesseria gonorrhea. 
 
Qu et al. report a nanostructured composite amperometric biosensor for choline (16), 
which is based on a functionalised CNT-PAni multilayer film. Carboxylic acid groups 
were attached to the CNTs and the films were prepared using a layer-by-layer 
assembly method. By linking choline oxidase (CHOD), a choline biosensor was 
prepared with a linear response range of 1 × 10−6 to 2 × 10−3 M, and a response time 
of 3s. The commonly encountered interference arising from AA and uric acid UA 
could be rejected successfully by the polymer. The same approach can be applied to 
immobilise other oxidase enzymes, such as glucose oxidase and cholesterol oxidase, 
for the fabrication of biosensors. This anti-interference biosensor displays a rapid 
response, an expanded linear response range, excellent reproducibility and good 
stability. 
 
Liu et al. report how polyaniline-carbon nanotube multilayer films can be prepared by 
the layer-by-layer assembly method and used for stable low-potential detection of β-
nicotinamide adenine dinucleotide (NADH) (7). The carbon nanotubes are modified 
with poly(aminobenzenesulfonic acid), and this acts as a PAni dopant, thus shifting its 
electroactivity to a neutral pH environment. Resulting films show good 
20 
 
electrocatalytic ability toward the oxidation of reduced NADH at a much lower 
potential than usual. The response is linear with concentration between 5 × 10-6 and 1 
× 10-3 M, and the detection limit can go down to 1 × 10-6 M. Therefore the system 
shows good potential for developing dehydrogenase-based biosensors depending on 
NADH as a cofactor. 
 
It is evident from the literature that incorporating nanoparticles into CNT-based 
glucose biosensors yields higher sensitivity. This is attributed to the enhanced 
catalytic activity and large surface area obtained by combining CNTs and 
nanoparticles. The most sensitive glucose biosensors however do not always operate 
in the most important clinical ranges as highlighted by Balasubramanian and 
Burghard (94). Tang et al. (137) have reported what can be regarded as an ideal yet 
practical sensor as it exhibits good sensitivity within a large clinically relevant 
detection range. In this case a CNT forest was grown directly on the graphite substrate 
followed by functionalisation with Pt nanoparticles, glucose oxidase and a thin layer 
of Nafion to improve stability. This system showed good reproducibility, 
demonstrated good correlation with independent clinical values in the analysis of 
glucose levels in serum and was able to deliver a signal in less than five seconds. A 
comparable sensor set-up was reported by Claussen et al. where they describe 
fabricating a ‘CNT forest’ like electrode decorated with Au-coated Pd nanocubes 
(138). The outer gold surface allowed for glucose oxidase functionalisation to yield a 
sensor with a wide working range and response time of just 6 seconds. Glucose can 
also be detected by a novel multilayer AU NP / MWNT / glucose oxidase membrane, 
developed by Liu et al. (139).  This membrane showed excellent electrocatalytic 
character for glucose biosensing at a relatively low potential (-0.2 V).  The resulting 
sensor could detect glucose up to 9.0 mM with a detection limit of 128 mM.  
 
 
4. Conclusion and Outlook 
A key aspect in biosensor development still remains the integration of the electrical 
component with the biological recognition molecule. The development of 
miniaturised biosensors with improved sensitivity requires immobilisation of 
biomolecules (including DNA, antibodies, aptamers, PNAs and enzymes) onto a 
surface, such that a maximum number of biomolecules per unit area can be attached, 
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while simultaneously being accessible to target species. Nanostructured surfaces are 
becoming increasingly significant in this regard as they possess high surface-to-
volume ratios, providing a greater number of sites for attachment. It is important to be 
able to functionalise nanostructures with specific biomolecules in a controllable and 
reproducible fashion. Biomolecular probes must also be carefully attached to prevent 
reactivity loss. We have shown here that both CPs and CNTs are effective transducers 
which can be used for the immobilisation of biomolecules. Both materials are 
conductive and stable in biological systems. Future requirements include improving 
immobilisation efficiency, tailoring nanostructured interfaces, and integrating these 
optimised nanobiosensors into external circuitry. The improvement of transduction 
mechanisms continues to be an important focus for biosensor research, and here we 
have shown that CPs and CNTs show great promise as efficient transducers. Graphene 
is the 2D form of CNTs and is also becoming increasingly important for biosensor 
applications (96). Quantum effects play a significant role in the behaviour of 
nanomaterials and can lead to novel optical, electrical and electrochemical properties. 
Careful engineering of materials at the nanoscale means that their small size and novel 
characteristics can be exploited for practical bio-applications. Physical and chemical 
properties of materials, such as colour, and ability to conduct charge, are different at 
the nanoscale making it possible to achieve a number of improvements over more 
traditional bulk substrates.  
 
The use of hybrid nanomaterials is becoming increasingly popular as it offers the 
opportunity to combine the advantageous properties of each individual constituent in a 
single composite material (140). Composites are suitable for multiplexed biosensing 
enabling the detection of multiple analytes using a single assay. The signal to noise 
ratio could be further improved using a combination of optimised nanomaterials and 
advanced circuitry. It is also interesting to consider the idea of personalised healthcare 
whereby wearable sensors are becoming increasingly important (141). Many 
challenges still remain in this area including the miniaturisation of integrated sensors 
and also issue of power supply. Thus as we have described, a wide range of 
nanomaterials and detection mechanisms are suitable for biosensing. The high surface 
area, porosity, and unique properties of nanomaterials facilitate the ultimate aim of a 
biosensor to achieve a significantly lower limit of biomolecule detection. The 
development of nanostructured biosensors is critical for further advancing the field of 
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medical diagnostics. Therefore, the importance of nanomaterials for biosensor 
development cannot be overstated.  
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Figure 1: Nanomaterials have many potential applications. Images (left) show; a 
CNT-based flexible full-colour e-paper device (Samsung, 2008), a flexible transparent 
CNT composite(142) (image courtesy of E. Lahiff), and a CNT-reinforced BMC bike 
used in the 2005 Tour de France Nanotechnology is expected to generate $2.5 trillion 
by 2015 (right: Sourced from Lux Research Inc.) 
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Figure 2: The relative size of some nanoparticles in comparison with biological molecules. 
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Figure 4: A SWNT can be visualised as a rolled-up sheet of graphite capped by half a C60 
molecule (left). CNTs can also exist as DWNTs and MWNTs. TEM images reveal the 
number of walls present (right shows 5, 2 and 7  layers)(26). Reproduced with permission 
from the Nature Publishing Group. 
 
 
 
Figure 4: Nanotubes possess an armchair, zig-zag or chiral structure depending on the angle 
at which they are rolled up (this determines n, m and θ values).  
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 (m = n) 
 26 
 
     
Figure 5: Biomolecules can be covalently attached to acid functionalities on CNT surfaces 
via EDC/NHS coupling with amide groups on a biomolecule (scheme shown top). TEM can 
be used to effectively image CNTs before (left) and after (right) biomolecule attachment. 
Dark spheres represent the iron core of HRP attached to CNT surfaces (Images courtesy of C. 
Lynam). 
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Figure 6:  The chemical structure of relevant CPs. Conjugated bonds facilitate improved 
electron transport. 
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Figure 7: The chemical bonding structure of the CP PAni is sensitive to the chemical 
environment of the material (left). In its nanoform, the material is more response than in the 
bulk form (right shows sensing results, reproduced with permission from the American 
Chemical Society.)(143).  
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Figure 8: Schematic representation of biomolecular sensing using carbon nanotubes in 
various device configuration and signal amplification strategies (114). Reproduced with 
permission from Wiley-VCH Verlag GmbH. 
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Table 1: Enhanced biosensor sensitivity can be achieved by incorporating NPs. 
Nanoparticle  Detection 
System 
Analyte Limit of detection (L.O.D) Ref 
CP (PAni) Photometric Cholesterol Oxidase 25mg/dL (71) 
CP (PTCA) Amperometric Pyruvate oxidase 
Glutamate oxidase 
0.3µM 
0.1µM 
(76) 
(15) 
CP (PPy) Amperometric Biotin-DNA 1nM (77) 
CP (PAni) Amperometric ODN 3.4x10-10 mol/L (0.34 nM) (78)  
CP (PAni) Voltammetry Gonorrhea 0.5x10-15 M (0.5 fM) (77) 
CP (Pani)  Capacitive human IgG 1.87 ng mL−1 (1.87 ng/ml) (144) 
PAni-gold Amperometric Tuberculosis DNA 0.125x10-18 M (0.125 aM) (77) 
Pani-CNTs  Electrochemical 
impedance 
spectroscopy 
NADH 1x10-6 M (1 µM) (77) 
MWNT Amperometric Cholesterol 0.2 mmol/l (0.2 mM) (101) 
MWNT-Pt  Differential pulse 
voltammetry 
DNA 1x10-11 mol/l (10 pM) (103) 
SWNT Amperometric PSA 4 pg/ml (110) 
SWNT FET Thrombin 10nM (145) 
SWNT FET Carcinoembryonic 
antigen 
300fM (129) 
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